Error loading resource. Please reload page.
Image Export Format
Image Size
Country | NEML Year | Rheumatology services | No. of meds on NEML | Section Juvenile Jt diseases | No. of meds on NEML Juvenile Jt diseases | NEMLc | No. of meds on NEMLc | Medicines Listed on NEML as on WHO EML 2021 | Additional medicines not on WHO EML |
---|
Country | NEML Year | Rheumatology services | No. of meds on NEML | Section Juvenile Jt diseases | No. of meds on NEML Juvenile Jt diseases | NEMLc | No. of meds on NEMLc | Medicines Listed on NEML as on WHO EML 2021 | Additional medicines not on WHO EML |
---|---|---|---|---|---|---|---|---|---|
Algeria | 2016 | Yes | 4 | No | No | Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine | Aurothiopropanol, Leflunomide | ||
Angola | 2021 | Yes | 7 | Yes | 1 | No | Azathioprine, Chloroquine, Hydroxychloroquine, Methotrexate, Penicillamine, Sulfasalazine, Acetylsalicylic acid | None | |
Benin | 2018 | Yes | 4 | No | Yes | 2 | Acetylsalicylic acid, Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine | Triamcinolone acetonide | |
Botswana | 2016 | Yes | 3 | No | No | Chloroquine, Methotrexate, Sulfasalazine | None | ||
Burkina Faso | 2020 | Yes | 2 | No | Yes | 0 | Hydroxychloroquine, Methotrexate | None | |
Burundi | 2012 | Yes | 0 | No | No | None | |||
Cameroon | 2017 | No | 0 | No | No | None | |||
Cape Verde | 2018 | Yes | 4 | No | No | Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine | Ciclosporin, Cyclophosphamide, MMF, Tacrolimus | ||
Central African Republic | 2017 | Yes | 0 | No | No | None | |||
Chad | 2022 | No | 0 | No | Yes | 0 | None | ||
Congo | 2013 | No | 4 | No | No | Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine | Ciclosporin, Cyclophosphamide | ||
Cote de ivoire | 2020 | Yes | 0 | No | No | None | |||
Djibouti | 2007 | Yes | 0 | No | No | None | |||
Democratic Republic of Congo | 2020 | Yes | 2 | No | Yes | 0 | Azathioprine, Methotrexate | None | |
Egypt | 2018 | Yes | 5 | No | No | Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine, Etanercept | Ciclosporin, Cyclophosphamide, Leflunomide | ||
Eritrea | 2010 | Yes | 1 | No | No | Sulfasalazine | None | ||
eSwatini | 2012 | Yes | 0 | No | No | None | |||
Ethiopia | 2020 | Yes | 5 | Yes | 1 | No | Azathioprine, Chloroquine, Methotrexate, Sulfasalazine, Adalimumab, Acetylsalicylic acid | Cyclosporin, Tacrolimus, Thalidomide, Lenalidomide | |
Ghana | 2019 | Yes | 10 | Yes | No | Azathioprine, Hydroxychloroquine, Methotrexate, Penicillamine, Sulfasalazine, Adalimumab, Certolizumab Pegol, Etanercept, Golimumab, Infliximab | Abatacept, Belimumab, Ciclosporin, Cyclophosphamide, leflunomide, MMF, Tacrolimus, Tofacitinib, Rituximab | ||
Guinea | 2012 | No | 3 | No | No | Hydroxychloroquine, Methotrexate, Sulfasalazine | None | ||
Kenya | 2019 | Yes | 8 | No | 6 | No | Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine, Etanercept, Golimumab, Infliximab, Acetylsalicylic acid | Abatacept, Cyclosporin, Cyclophosphamide, Leflunomide, MMF, Rituximab, Tacrolimus, Tocilizumab | |
Lesotho | 2005 | No | 0 | No | No | None | |||
Liberia | 2017 | Yes | 5 | Yes | 1 | No | Azathioprine, Chloroquine, Methotrexate, Penicillamine, Sulfasalazine, Acetylsalicylic acid | Ciclosporin | |
Libya | 2019 | Yes | 8 | No | 1 | No | Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine, Adalimumab, Certolizumab Pegol, Etanercept, Infliximab, Acetylsalicylic acid | Anakinra, Cyclosporin, Leflunomide, MMF, Tocilizumab, Triamcinolone acetonide | |
Madagascar | 2008 | No | 3 | No | No | Methotrexate, Penicillamine, Sulfasalazine | None | ||
Malawi | 2015 | Yes | 1 | Yes | 1 | No | Methotrexate, Acetylsalicylic acid | Ciclosporin | |
Mali | 2019 | Yes | 5 | No | No | Azathioprine, Hydroxychloroquine, Methotrexate, Penicillamine, Sulfasalazine | None | ||
Mauritania | 2012 | Yes | 0 | No | No | None | |||
Morocco | 2014 | No | 4 | No | No | Azathioprine, Chloroquine, Methotrexate, Sulfasalazine | None | ||
Mozambique | 2017 | Yes | 4 | No | No | Chloroquine, Methotrexate, Penicillamine, Sulfasalazine | Ciclosporin, cyclophosphamide | ||
Namibia | 2016 | Yes | 5 | No | No | Azathioprine, Hydroxychloroquine, Methotrexate, Penicillamine, Sulfasalazine | Ciclosporin | ||
Nigeria | 2020 | Yes | 4 | Yes | 1 | Yes | 5 | Acetylsalicylic acid, Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine, Etanercept | Rituximab, Tocilizumab, Ciclosporin, Cyclophosphamide, MMF, Sulfasalazine |
Rwanda | 2015 | Yes | 1 | No | Yes | 2 | Methotrexate | None | |
Senegal | 2018 | No | 0 | No | No | None | |||
Seychelles | 2010 | Yes | 2 | No | No | Chloroquine, Methotrexate | None | ||
Sierra Leone | 2019 | Yes | 1 | No | No | Chloroquine | None | ||
Somalia | 2019 | Yes | 2 | No | No | Azathioprine, Methotrexate | Ciclosporin | ||
South Africa | 2023 | Yes | 4 | No | Yes | 5 | Azathioprine,Chloroquine, Methotrexate, Sulfasalazine, Adalimumab | Methyl prednisolone Acetate, Cyclosporin, Cyclophosphamide, Rituximab | |
South Sudan | 2018 | No | 3 | No | No | Azathioprine, Chloroquine, Methotrexate | Ciclosporin | ||
Sudan | 2014 | No | 5 | No | No | Azathioprine, Hydroxychloroquine, Methotrexate, Penicillamine, Sulfasalazine | Cyclophosphamide, Rituximab | ||
Tanzania | 2021 | Yes | 4 | Yes | 1 | No | Azathioprine, Hydroxychloroquine, Methotrexate, Sulfasalazine, Acetylsalicylic acid | Ciclosporin, Cyclophosphamide, MMF | |
The Gambia | 2001 | Yes | 0 | No | No | None | |||
Togo | 2012 | No | 4 | No | No | Hydroxychloroquine, Methotrexate, Penicillamine, Sulfasalazine | None | ||
Tunisia | 2016 | Yes | 9 | No | No | Azathioprine, Chloroquine, Hydroxychloroquine, Methotrexate, Penicillamine, Sulfasalazine, Adalimumab, Etanercept, Infliximab | None | ||
Uganda | 2016 | Yes | 3 | No | No | Azathioprine, Chloroquine, Methotrexate | Cyclosporin | ||
Zambia | 2020 | Yes | 1 | No | No | Hydroxychloroquine | Acetylsalicylic acid | ||
Zimbabwe | 2015 | Yes | 3 | Yes | 1 | No | Chloroquine, Methotrexate, Sulfasalazine, Acetylsalicylic acid | None |
We use cookies to improve user experience, and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By continuing to the site, you consent to store on your device all the technologies described in our Privacy Policy. Please read our Terms and Conditions and Privacy Policy for full details.